Cargando…
Novel Methylselenoesters Induce Programed Cell Death via Entosis in Pancreatic Cancer Cells
Redox active selenium (Se) compounds have gained substantial attention in the last decade as potential cancer therapeutic agents. Several Se compounds have shown high selectivity and sensitivity against malignant cells. The cytotoxic effects are exerted by their biologically active metabolites, with...
Autores principales: | Khalkar, Prajakta, Díaz-Argelich, Nuria, Antonio Palop, Juan, Sanmartín, Carmen, Fernandes, Aristi P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6213452/ https://www.ncbi.nlm.nih.gov/pubmed/30241340 http://dx.doi.org/10.3390/ijms19102849 |
Ejemplares similares
-
Novel Methylselenoesters as Antiproliferative Agents
por: Díaz-Argelich, Nuria, et al.
Publicado: (2017) -
Methylseleninic Acid Sensitizes Ovarian Cancer Cells to T-Cell Mediated Killing by Decreasing PDL1 and VEGF Levels
por: Nair, Deepika, et al.
Publicado: (2018) -
Cell Death by Entosis: Triggers, Molecular Mechanisms and Clinical Significance
por: Kianfar, Mostafa, et al.
Publicado: (2022) -
Entosis: The emerging face of non-cell-autonomous type IV programmed death [Image: see text]
por: Martins, Isabelle, et al.
Publicado: (2017) -
Genetic and clinical correlates of entosis in pancreatic ductal adenocarcinoma
por: Hayashi, Akimasa, et al.
Publicado: (2020)